Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride channels are a diverse group of anion-selective membrane proteins that facilitate the passive movement of chloride ions and, in some cases, other anions across cellular membranes. They play essential roles in maintaining ion homeostasis, regulating cell volume, controlling electrical excitability, and supporting transepithelial transport in various tissues. Dysfunction or mutations in specific chloride channel genes cause diseases such as cystic fibrosis (CFTR mutation) or myotonia congenita (ClC‑1 mutation). Chloride channels are targets for drug development aimed at treating these conditions among others.
Chloride channel opening allows rapid movement of chloride ions down their electrochemical gradient, resulting in hyperpolarization or depolarization. Some CLC family members act as electrogenic antiporters.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride Channel (None).